Neuroprotective Activities of Heparin, Heparinase III, and Hyaluronic Acid on the Aβ42-Treated Forebrain Spheroids Derived from Human Stem Cells

Research paper by Julie Bejoy, Liqing Song, Zhe Wang, Qing-Xiang Sang, Yi Zhou, Yan Li

Indexed on: 13 Jul '18Published on: 28 Jun '18Published in: ACS Biomaterials Science & Engineering


Extracellular matrix (ECM) components of the brain play complex roles in neurodegenerative diseases. The study of microenvironment of brain tissues with Alzheimer’s disease revealed colocalized expression of different ECM molecules such as heparan sulfate proteoglycans (HSPGs), chondroitin sulfate proteoglycans (CSPGs), matrix metalloproteinases (MMPs), and hyaluronic acid. In this study, both cortical and hippocampal populations were generated from human-induced pluripotent stem cell-derived neural spheroids. The cultures were then treated with heparin (competes for Aβ affinity with HSPG), heparinase III (digests HSPGs), chondroitinase (digests CSPGs), hyaluronic acid, and an MMP-2/9 inhibitor (SB-3CT) together with amyloid β (Aβ42) oligomers. The results indicate that inhibition of HSPG binding to Aβ42 using either heparinase III or heparin reduces Aβ42 expression and increases the population of β-tubulin III+ neurons, whereas the inhibition of MMP2/9 induces more neurotoxicity. The results should enhance our understanding of the contribution of ECMs to the Aβ-related neural cell death.

Figure 10.1021/acsbiomaterials.8b00021.1.jpg
Figure 10.1021/acsbiomaterials.8b00021.2.jpg
Figure 10.1021/acsbiomaterials.8b00021.3.jpg
Figure 10.1021/acsbiomaterials.8b00021.4.jpg
Figure 10.1021/acsbiomaterials.8b00021.5.jpg
Figure 10.1021/acsbiomaterials.8b00021.6.jpg
Figure 10.1021/acsbiomaterials.8b00021.7.jpg
Figure 10.1021/acsbiomaterials.8b00021.8.jpg
Figure 10.1021/acsbiomaterials.8b00021.9.jpg
Figure 10.1021/acsbiomaterials.8b00021.10.jpg